Nonhuman Adenoviral Vector-Based Platforms and Their Utility in Designing Next Generation of Vaccines for Infectious Diseases

Several human adenoviral (Ad) vectors have been developed for vaccine delivery owing to their numerous advantages, including the feasibility of different vector designs, the robustness of elicited immune responses, safety, and scalability. To expand the repertoire of Ad vectors for receptor usage an...

Full description

Bibliographic Details
Published in:	Viruses
Main Authors:	Marwa Alhashimi, Ahmed Elkashif, Ekramy E. Sayedahmed, Suresh K. Mittal
Format:	Article
Language:	English
Published:	MDPI AG 2021-07-01
Subjects:	adenoviral vector nonhuman adenoviral vector viral vector vaccine infectious disease
Online Access:	https://www.mdpi.com/1999-4915/13/8/1493

Similar Items

Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines
by: Ekramy E. Sayedahmed, et al.
Published: (2020-10-01)

Adenoviral Vector-Based Vaccine Expressing Hemagglutinin Stem Region with Autophagy-Inducing Peptide Confers Cross-Protection Against Group 1 and 2 Influenza A Viruses
by: Wen-Chien Wang, et al.
Published: (2025-01-01)

Bovine Adenoviral Vector-Based Platform for Vaccine Development
by: Ekramy E. Sayedahmed, et al.
Published: (2025-05-01)

Significance of Preexisting Vector Immunity and Activation of Innate Responses for Adenoviral Vector-Based Therapy
by: Wen-Chien Wang, et al.
Published: (2022-12-01)

Developing the next-generation of adenoviral vector vaccines
by: Alexander T. Sampson, et al.
Published: (2025-12-01)

Enhancement of mucosal innate and adaptive immunity following intranasal immunization of mice with a bovine adenoviral vector
by: Ekramy E. Sayedahmed, et al.
Published: (2023-11-01)

Next-Generation Adenoviral Vector-Based Vaccines for Severe Acute Respiratory Syndrome Coronavirus-2
by: Muralimanohara S. T. Murala, et al.
Published: (2025-04-01)

In vitro immune evaluation of adenoviral vector-based platform for infectious diseases
by: Joanna Baran, et al.
Published: (2023-12-01)

Development of adenoviral vectors that transduce Purkinje cells and other cerebellar cell-types in the cerebellum of a humanized mouse model
by: Emre Kul, et al.
Published: (2024-06-01)

High-Throughput Screening for the Prevalence of Neutralizing Antibodies against Human Adenovirus Serotype 5
by: Jochen M. Wettengel, et al.
Published: (2024-02-01)

An Adenoviral Vector as a Versatile Tool for Delivery and Expression of miRNAs
by: Jonas Scholz, et al.
Published: (2022-09-01)

Adenoviral Vectors as Vaccines for Emerging Avian Influenza Viruses
by: Lucas J. Kerstetter, et al.
Published: (2021-01-01)

Type I Interferon, Induced by Adenovirus or Adenoviral Vector Infection, Regulates the Cytokine Response to Lipopolysaccharide in a Macrophage Type-Specific Manner
by: Mareike D. Maler, et al.
Published: (2024-03-01)

DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 1)
by: L. V. Cherenova, et al.
Published: (2017-05-01)

DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 2)
by: L. V. Cherenova, et al.
Published: (2017-08-01)

mRNA and Adenoviral Vector Vaccine Platforms Utilized in COVID-19 Vaccines: Technologies, Ecosystem, and Future Directions
by: Ryo Okuyama
Published: (2023-11-01)

Adenovirus as a Vector and Oncolytic Virus
by: Wataru Matsunaga, et al.
Published: (2023-06-01)

Adenoviral Vectors for Gene Therapy of Hereditary Diseases
by: Anna Muravyeva, et al.
Published: (2024-12-01)

Adenoviral-vectored epigraph vaccine elicits robust, durable, and protective immunity against H3 influenza A virus in swine
by: Erika Petro-Turnquist, et al.
Published: (2023-05-01)

Lung Organoids from hiPSCs Can Be Efficiently Transduced by Recombinant Adeno-Associated Viral and Adenoviral Vectors
by: Lyubava Belova, et al.
Published: (2025-04-01)

Gene Therapy: Will the Promise of Optimizing Lung Allografts Become Reality?
by: Qimeng Gao, et al.
Published: (2022-07-01)

Adenoviral Vector Codifying for TNF as a Co-Adjuvant Therapy against Multi-Drug-Resistant Tuberculosis
by: Sujhey Hernández-Bazán, et al.
Published: (2023-12-01)

Transdermal delivery of PeptiCRAd cancer vaccine using microneedle patches
by: Carmine D'Amico, et al.
Published: (2025-03-01)

Development of NP-Based Universal Vaccine for Influenza A Viruses
by: Ekramy E. Sayedahmed, et al.
Published: (2024-02-01)

Guillain-Barré syndrome and COVID-19 vaccines: focus on adenoviral vectors
by: Piotr Rzymski
Published: (2023-04-01)

Preclinical model for phenotypic correction of dystrophic epidermolysis bullosa by in vivo CRISPR-Cas9 delivery using adenoviral vectors
by: Marta García, et al.
Published: (2022-12-01)

The Adenovirus Vector Platform: Novel Insights into Rational Vector Design and Lessons Learned from the COVID-19 Vaccine
by: Erwan Sallard, et al.
Published: (2023-01-01)

Advances and Future Challenges in Recombinant Adenoviral Vectored H5N1 Influenza Vaccines
by: Jianfeng Zhang
Published: (2012-11-01)

Evaluation of the human type 3 adenoviral dodecahedron as a vector to target acute myeloid leukemia
by: Benjamin Caulier, et al.
Published: (2021-03-01)

Multi-targeted gene silencing strategies inhibit replication of Canine morbillivirus
by: Otávio Valério de Carvalho, et al.
Published: (2020-11-01)

A phase II/III, randomized, double-blind, placebo-controlled trial to evaluate immunogenicity and safety of the Gam-COVID-Vac combined vector vaccine in the prophylactic treatment for SARS-СoV-2 infection in the United Arab Emirates
by: Ahmed A.K. AlHammadi, et al.
Published: (2025-08-01)

Role of homologous recombination/recombineering on human adenovirus genome engineering: Not the only but the most competent solution
by: Lisa-Marie Dawson, et al.
Published: (2024-03-01)

Chimpanzee adenoviral vector prime-boost regimen elicits potent immune responses against Ebola virus in mice and rhesus macaques
by: Xi Yang, et al.
Published: (2019-01-01)

Trained ILCs confer adaptive immunity-independent protection against influenza
by: Wadzanai P. Mboko, et al.
Published: (2025-09-01)

Short-Term Adverse Effects Following Booster Dose of Inactivated-Virus vs. Adenoviral-Vector COVID-19 Vaccines in Algeria: A Cross-Sectional Study of the General Population
by: Mohamed Lounis, et al.
Published: (2022-10-01)

Silk‐Gel Powered Adenoviral Vector Enables Robust Genome Editing of PD‐L1 to Augment Immunotherapy across Multiple Tumor Models
by: Ming Wu, et al.
Published: (2023-04-01)

Development of novel vaccine vectors: Chimpanzee adenoviral vectors
by: Jingao Guo, et al.
Published: (2018-07-01)

Adenoviral Vectors Meet Gene Editing: A Rising Partnership for the Genomic Engineering of Human Stem Cells and Their Progeny
by: Francesca Tasca, et al.
Published: (2020-04-01)

A novel simian adenovirus-vectored COVID-19 vaccine elicits effective mucosal and systemic immunity in mice by intranasal and intramuscular vaccination regimens
by: Panli Zhang, et al.
Published: (2023-12-01)

High-Capacity Adenoviral Vectors Permit Robust and Versatile Testing of <i>DMD</i> Gene Repair Tools and Strategies in Human Cells
by: Marcella Brescia, et al.
Published: (2020-04-01)